Market Cap: $5.32M
LC
Lexaria Bioscience Corp.
LEXX
NASDAQ (NASDAQ Capital Market)USD
Market Cap: $5.32M
Lexaria Bioscience: Pioneering Innovations in Drug Delivery Systems Lexaria Bioscience stands at the forefront of the cannabis and pharmaceutical industries with its innovative drug delivery technolog…
Lexaria Bioscience's Innovations in Drug Delivery: A Game Changer in the Industry Lexaria Bioscience is making significant strides in the pharmaceutical and nutraceutical sectors with its proprietary…
Lexaria Bioscience Advances Drug Delivery Technology in Phase 1b Study Lexaria Bioscience Corp. has recently completed a significant milestone with the conclusion of its Phase 1b chronic study, GLP-1-…
Lexaria Bioscience Advances Drug Delivery Research with Promising Study Results Lexaria Bioscience Corp. has recently concluded its Phase 1b, 12-week chronic study, designated GLP-1-H24-4, in Australi…
Lexaria Bioscience Strives for Biotech Innovation Amid Growing Interest Lexaria Bioscience Corp. is making waves in the biotechnology sector with its commitment to developing innovative delivery metho…
Lexaria Bioscience's Innovative Approach Drives Market Interest Lexaria Bioscience Corp. stands out in the biotechnology sector for its groundbreaking research and development in enhancing the deliver…
Lexaria Bioscience Advances in Drug Delivery Technology Lexaria Bioscience continues to make significant strides in the development of its patented DehydraTECH technology, which enhances the oral deli…